Foundation turns spotlight on psoriatic arthritisJune 26, 2014Psoriatic ArthritisSpondyloarthropathies
Low infliximab start dose appears effective in psoriatic arthritisJune 26, 2014Psoriatic ArthritisSpondyloarthropathies
Treat to target shows durable improvements in psoriatic arthritisJune 12, 2014SpondyloarthropathiesPsoriatic Arthritis
Brodalumab outperformed placebo for psoriatic arthritisJune 11, 2014SpondyloarthropathiesPsoriatic Arthritis
Apremilast appears to have multiple, lasting benefits in psoriatic arthritisMay 14, 2014SpondyloarthropathiesPsoriatic Arthritis
FDA approves PDE-4 inhibitor for treating psoriatic arthritis March 21, 2014SpondyloarthropathiesPsoriatic Arthritis
Gut-joint connection promising in psoriatic arthritisFebruary 26, 2014SpondyloarthropathiesPsoriatic Arthritis
Shift in approach needed for managing inflammatory arthritis in pregnancy February 5, 2014Rheumatoid ArthritisSpondyloarthropathiesPsoriatic ArthritisAnkylosing spondylitis
Apremilast’s positive study results made it the talk of ACR 2013November 14, 2013SpondyloarthropathiesPsoriatic Arthritis
Treat-to-target approach for psoriatic arthritis found beneficialNovember 4, 2013SpondyloarthropathiesPsoriatic Arthritis
Ustekinumab approved for psoriatic arthritis September 23, 2013SpondyloarthropathiesPsoriatic Arthritis
Apremilast effects sustained at 1 year in psoriatic arthritisJune 25, 2013SpondyloarthropathiesPsoriatic Arthritis
